VaxInnate, a US-based biotechnology firm, has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID) to fund the development of a recombinant vaccine for the prevention of dengue. The grant will provide ...
The National Institutes of Health (NIH) has awarded a Phase I small business innovation research (SBIR) grant to TriLink BioTechnologies to use its expertise in nucleic acid chemistry and develop an approach to RNA sample preparation for ...
Tags: nucleic acid chemistry, TriLink, NGS RNA Sample Preparation
Researchers at the National Institutes of Health (NIH) have begun enrolling volunteers for clinical trials to find effective treatments for influenza. One of the studies will assess if treatment with the influenza drug oseltamivir reduces ...
Epic Sciences, a developer of diagnostic tests, has received a Phase II small business innovation research (SBIR) contract from the National Cancer Institute (NCI) and the National Institutes of Health (NIH) for the development of a lung ...
Tags: lung cancer diagnostic, blood test, Epic
The National Cancer Institute (NCI) and the National Institutes of Health (NIH) have announced a Phase II small business innovation research (SBIR) contract to Epic Sciences for the development of a lung cancer diagnostic blood test. The ...
Genea Stem Cells Pty Ltd (GSC), a supplier and developer of disease-specific human stem cells, has announced that 25 of its disease specific embryonic pluripotent stem cell lines have been placed on the USA National Institutes of Health ...
Edison Pharmaceuticals has started a phase 2B study, which will investigate new treatments for Friedreich's ataxia. The trial is entitled Safety and Efficacy Study of EPI-743 on Visual Function in Patients with Friedreich's Ataxia. It is ...
Tags: Edison Pharmaceuticals, disease severity, neuromuscular function
National Institutes of Health(NIH),under the SHIFT initiative,has granted two Small Business Innovative Research(SBIR)Phase I awards,totaling$800k over 2 years,to Circulomics. Circulomics will use the grants to develop its Ligo-miR ...
Tags: NIH, SHIFT, SBIR, Ligo miR microRNA assay technology
Fraunhofer Center for Molecular Biotechnology (FhCMB) has received a contract from the US National Institute of Allergy and Infectious Diseases to develop vaccine technologies for advancing the next generation of anthrax vaccines. ...
Tags: FhCMB, anthrax vaccines, NIH
The US Food and Drug Administration (FDA) has cleared Sigma-Tau Pharmaceuticals' topical ophthalmic therapeutic to treat corneal cystine crystals in cystinosis patients. The CYSTARAN 0.44% solution, which is developed in collaboration ...
Neurotrack has introduced a new computer-based recognition memory test to diagnose Alzheimer's disease years before clinical symptoms appear. The launch was based on the results from a 5-year longitudinal study, funded by the NIH, which ...
Tags: Neurotrack, computer-based recognition memory test, Alzheimer's disease
Quest Diagnostics has introduced a molecular cervical cancer test based on National Institutes of Health's TERC gene marker to identify molecular changes to cervical cells that increase the chance of a woman to develop cervical cancer. ...
Tags: cervical cancer TERC test, Quest Diagnostics, TERC results
Northrop Grumman has won bioinformatics integration support contract (BISC) worth $30m from the National Institutes of Health (NIH) for information technology and bioinformatics technology services. NIH will leverage the technology in ...
Tags: Northrop Grumman, BISC, immunology, immune-mediated diseases
Linguamatics has launched a new cloud-based clinical trials text mining solution, I2E. The platform is used for mining clinical trials data for decision support in biomedical research, clinical trials study design, site selection and ...
Tags: cloud-based clinical trials, Linguamatics, clinical platform
The US Federal Drug Administration (FDA) has received an application from Sobi for Kineret (anakinra) for the indication of neonatal-onset multisystem inflammatory disease (NOMID). The filing is made under an Orphan Drug Designation for ...